# Nometech Oy \- Medical Device Regulatory \& Quality Services: Medical device quality, ISO 13485, FDA submissions, EU MDR compliance and product development services from idea to approval\. > Medical device regulatory and quality services for health tech and medical device companies, from development to market entry\. Generated by Yoast SEO v28.1, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [ISO 13485](https://nometech.eu/iso13485/) - [Insights on Medical Device Quality and Regulatory Affairs](https://nometech.eu/blog-posts/) - [Nometech Oy](https://nometech.eu/) - [EC REP](https://nometech.eu/european-authorized-representative-medical-devices/) - [About Nometech \| Medical Device Regulatory Experts from Finland](https://nometech.eu/about/) ## Posts - [The Three Strategic Headaches of a MedTech Startup Founder and How to Solve Them Early](https://nometech.eu/the-three-strategic-headaches-of-a-medtech-startup-founder-and-how-to-solve-them-early/) - [ISO 13485 Explained: A Practical Guide for Medical Device Companies](https://nometech.eu/what-is-iso-13485/): ISO 13485 is the foundation of quality management for medical device companies\. In this first article of our ISO 13485 Explained series, we explore what the standard is, why it matters, and how it helps organizations build a practical and compliant Quality Management System\. - [FDA \- Human Factors Validation](https://nometech.eu/fda-human-factors-validation/): FDA’s 2026 Human Factors guidance clarifies what information should be included in medical device submissions\. Here’s what changed, what the new HF Submission Categories mean, and why it matters\. - [Navigating the Regulatory Landscape for Implantable Medical Devices](https://nometech.eu/navigating-the-regulatory-landscape-for-implantable-medical-devices/): Implantable medical devices face some of the strictest regulatory requirements under MDR and FDA frameworks\. This article explores clinical evaluation, PMCF, risk management, technical documentation, cybersecurity, and regulatory strategy for implantable medical devices\. - [Post\-Market Surveillance under EU MDR and FDA: From Compliance to Strategic Advantage](https://nometech.eu/post-market-surveillance-eu-mdr-fda/) ## Categories - [FDA](https://nometech.eu/category/fda/) - [EU MDR](https://nometech.eu/category/eu-mdr/) - [CE](https://nometech.eu/category/ce/) - [QMS](https://nometech.eu/category/qms/) - [Regulatory](https://nometech.eu/category/regulatory/) ## Tags - [technical documentation](https://nometech.eu/tag/technical-documentation/) - [risk management](https://nometech.eu/tag/risk-management/) - [FDA](https://nometech.eu/tag/fda/) - [quality management system](https://nometech.eu/tag/quality-management-system/) - [clinical evaluation](https://nometech.eu/tag/clinical-evaluation/) ## Optional - [Sitemap index](https://nometech.eu/sitemap_index.xml)